Erythroderma after clodronate treatment.
作者信息
Pajus I, Lestang P, Lioté F, Dryll A
机构信息
Hôpital Lariboisiére, Paris, France.
出版信息
BMJ. 1993 Aug 21;307(6902):484. doi: 10.1136/bmj.307.6902.484.
Abstract
摘要
相似文献
1
Erythroderma after clodronate treatment.氯膦酸盐治疗后出现红皮病。
BMJ. 1993 Aug 21;307(6902):484. doi: 10.1136/bmj.307.6902.484.
2
Ketoconazole therapy and exfoliative erythroderma.酮康唑治疗与剥脱性红皮病
Arch Dermatol. 1983 Feb;119(2):97-8.
3
Warfarin-induced erythroderma.
Australas J Dermatol. 2015 Feb;56(1):e15-7. doi: 10.1111/ajd.12140. Epub 2014 Mar 4.
4
Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
Int J Dermatol. 2016 Apr;55(4):e214-5. doi: 10.1111/ijd.13273. Epub 2016 Feb 24.
5
[A patient with erythroderma desquamativa and eosinophilia].
Semergen. 2013 May-Jun;39(4):242-3. doi: 10.1016/j.semerg.2013.01.002. Epub 2013 Mar 7.
6
Photoallergic erythroderma due to doxycycline therapy of erythema chronicum migrans.多西环素治疗慢性游走性红斑所致的光变应性红皮病。
Acta Derm Venereol. 2011 Oct;91(6):734-6. doi: 10.2340/00015555-1161.
7
Metoprolol-induced Total Body Erythroderma.美托洛尔诱发的全身性红皮病
J Gen Intern Med. 2017 Feb;32(2):221-222. doi: 10.1007/s11606-016-3900-2. Epub 2016 Oct 19.
8
Erythroderma after intravenous injection of methylprednisolone.静脉注射甲泼尼龙后出现红皮病。
Contact Dermatitis. 1991 Jul;25(1):68-70. doi: 10.1111/j.1600-0536.1991.tb01783.x.
9
Interstitial granulomatous drug reaction presenting as erythroderma: remission after discontinuation of enalapril maleate.
Br J Dermatol. 2008 May;158(5):1143-5. doi: 10.1111/j.1365-2133.2008.08469.x. Epub 2008 Feb 16.
10
Erythroderma associated with St John's wort.与圣约翰草相关的红皮病。
Br J Dermatol. 2000 Nov;143(5):1127-8. doi: 10.1046/j.1365-2133.2000.03879.x.
引用本文的文献
1
Therapeutic Dimensions of Bisphosphonates: A Clinical Update.双膦酸盐的治疗维度：临床最新进展
Int J Prev Med. 2020 Oct 5;11:166. doi: 10.4103/ijpvm.IJPVM_33_19. eCollection 2020.
2
Adverse effects of bisphosphonates. A comparative review.双膦酸盐的不良反应。一项比较性综述。
Drug Saf. 1996 Mar;14(3):158-70. doi: 10.2165/00002018-199614030-00003.
3
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.氯膦酸盐。其药理学特性及对溶骨性骨病治疗效果的综述。
Drugs. 1994 Jun;47(6):945-82. doi: 10.2165/00003495-199447060-00007.
本文引用的文献
1
Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.氨基羟丙基二膦酸二钠（APD）治疗骨病期间的副作用。
Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):828-9. doi: 10.1136/bmj.288.6420.828-a.
2
[Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].[药物意外或毒性作用的归因。法国所用方法的更新]
Therapie. 1985 Mar-Apr;40(2):111-8.
3
Severe reaction to diphosphonate: implications for treatment of Paget's disease.
BMJ. 1988 Sep 3;297(6648):592-3. doi: 10.1136/bmj.297.6648.592-a.
4
Tolerability and safety of clodronate therapy in bone diseases.氯膦酸盐治疗骨疾病的耐受性和安全性。
Int J Clin Pharmacol Res. 1991;11(2):107-14.
Zotero 插件